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Lymphocytes continually recirculate between thebloodstream, extravascular tissues,
lymphnodes, and lymph (1). Thiscirculation ofcells couldprovide ameans whereby
largenumbers oflymphocytes with different antigen specificities mayencounter an-
tigen, allowing specific antigen-reactive cells to be selected out and to accumulate
at sites of antigen deposition. Lymphocytes leave the blood at particular traffic sites
inlymph nodes where theypass betweenthe endothelialcellsofpost-capillaryvenules
(PCV).t Such lymphocyte-endothelial interactions appear to be mediated by specific
cell surface molecules (2, 3). From studies on afferent lymph, it is clear that there
is a continuous low grade migration of lymphocytes and monocytes from blood to
lymph (4). Ofthe lymphocytes enteringa lymph node, N10% may be derived from
afferent lymph, while85-90% are deriveddirectly from the bloodviaPCV(4). Afferent
lymphatics also transport antigen to the lymphnode, as well as cell types other than
lymphocytes, such as macrophages, dendritic cells, and under some circumstances,
e.g., accute inflammation, granylocytes, and erythrocytes (4, 5). Afferent lymph has
also been shown to contain fewer B lymphocytes than blood or efferent lymph (6),
andafferent cells behave differentlyfromefferentlymphocytes in graft-vs.-host reac-
tions (6, 7).
The sheephas been used extensively forstudies onlymphocyte recirculation, par-
ticularly the examination ofcells migrating in afferent and efferent lymph (5, 8, 9).
Here, weextend these studies usinga panel ofmAbs and flow cytometry to identify
the phenotypes of cells in the afferent lymph and efferent lymph draining to and
from asingle lymph node as well as theblood ofindividualsheep. The strikingdiffer-
ences in the distribution of lymphocyte subpopulations between compartments,
reported in this paper, suggest that the exit oflymphocyte subpopulations (defined
by ourpanel ofmAbs) from the blood via traffic sites in lymph nodes and peripheral
vascular beds is nonrandom.
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Materials and Methods
Animals and Surgery.
￿
Merino ewes, 8-10 mo old, were used in all experiments. They were
kept in metabolism cages and given lucerne chaff and water ad libitum .
The popliteal efferent lymph duct and afferent lymph duct draining the lower part of the
right hind leg were cannulated, as described by Hall and Morris (10). At the time ofsurgery,
a cannula was placed in the jugular vein for taking blood samples.
Lymph Collection.
￿
Lymph was collected continuously in sterile polyethylene bottles that
contained 1 ml ofnormal saline supplemented with 500 U ofpreservative-free heparin (Com-
monwealth Serum Laboratories, Melbourne, Australia), 500 IU of penicillin, and 500 ug
ofstreptomycin (Flow Laboratories, Melbourne, Australia). The lymph collection bottles were
changed at regular intervals. The cell concentration in each collection was determined using
a Coulter Counter fitted with a 100-wM aperature tube (model FN; Coulter Electronics Ltd.,
Dunstable, Bedfordshire, UK) . At least 3 d after surgery, when the changes in the lymph
caused by surgery and anesthesia had subsided, lymph was collected for 8 h and the pheno-
type of cells in lymph and blood was determined. The popliteal lymph node was removed
at the same time for preparation of cell suspensions and immunohistology.
mAbs.
￿
mAbs to sheep lymphocyte antigens were produced within the Department ofVeteri-
nary Preclinical Sciences, Melbourne University, (Melbourne, Australia) and were used as
undiluted tissue culture supernatants.
mAbs were characterized by immunoprecipitation and molecular weight analysis and by
immunohistology and tissue distribution. Table I summarizes the reactivities of the mAbs
and gives the references describing their characterization.
CellSuspensions.
￿
Cell suspensions of lymph nodes were prepared by gentle teasing oflymph
nodes with forceps in PBS containing 1% BSA. Clumps were removed by filtering the sus-
pension through cotton gauze, and the cells were washed three times in a solution ofPBS/BSA.
Peripheral blood was taken from the jugular vein in a solution of EDTA (6.2 mg/ml blood ;
Ajax Chemicals, Melbourne, Australia) and treated with ammonium chloride to lyse RBC .
Ammonium chloride/Tris lysis buffer was prepared by mixing 9 vol of 0.83% ammonium
chloride with 1 vol of 0.17 M Tris, and the pH of the Tris-NH4Cl solution was adjusted to
7.2 before use. The lysis buffer was warmed to 37°C and 5 ml of buffer was used per 1 ml
of blood. Erythrocytes usually lysed within 1-3 min. Blood lymphocytes obtained after am-
monium chloride lysis were identified on the flow cytometer using 0° and 90° light scatter.
Immunoftuorescence and Flow Cytometry.
￿
For single-color immunofluorescent staining with
mAbs, 106 cells were reacted with 50 pl of neat tissue culture supernatant for 30 min at 4°C,
were washed three times in a solution ofPBS/BSA, and were then reacted with FITC-sheep
anti-mouse Ig (Silenus Laboratories, Melbourne, Australia). FITC-donkey anti-sheep Ig
(Silenus Laboratories) was used to enumerate cell surface Ig' (slg') lymphocytes. After
staining, cells were fixed in a solution of 1% paraformaldehyde in PBS containing 0.1% so-
dium azide.
Analysis of sheep lymphocytes by flow Cytometry was performed using a FAGS II (Becton
Dickinson FAGS Systems, Sunnyvale, CA). For one-color immunofluorescent analysis or for-
ward angle light scatter analysis, 104 cells were analyzed per sample and dead cells were ex-
cluded on the basis of forward light scatter.
Immunoperoxidase Staining.
￿
Tissues were submersed in OCT embedding compound (Lab-
Tek, Naperville, IL), snap frozen in liquid nitrogen, and stored at -70°C. Frozen sections
(3-5 1tm) were placed on xylene-cleaned slides, air dried for 1 h, and fixed in absolute al-
cohol for 10 min at 4°C. Sections were exposed to mAbs for 1 h, washed with PBS, and then
reincubated for 1 h with peroxidase-conjugated rabbit anti-mouse Ig (Dako Immunoglobu-
lins, Copenhagen, Denmark). After washing, slides were developed in a solution ofdiaminoben-
zidene tetrahydrochloride (Sigma Chemical Co., St. Louis, MO; 0 .5 mg/ml in a 0.25 M Tris,
0.14 M NaCl, pH 7.6) and H202 (0.01%). Sections were then lightly counterstained with
hematoxylin.
Cytospots ofefferent or afferent lymph lymphocytes were prepared using a cytocentrifuge
(Shandon Southern Instruments Inc., St. Sewickley, PA), as previously described (11). Slides
were stained by the immunoperoxidase method as described above for tissue sections.
Arithmetic means of the proportion of stained cells in each compartment were compared
using the Mann-Whitney U test (12).J
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TABLE I
Reactivity of mAbs to Sheep Leukocytes
Results
Phenotypic Analysis ofLymphocytes Obtained Simultaneouslyfrom Afferent Lymph, Efferent
Lymph, Blood, and Popliteal Lymph Node. Lymphocytes were taken simultaneously
from afferent lymph, efferent lymph, blood, and the popliteal lymph node of in-
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FIGURE 1.
￿
FRCS analysis oflymphocytes from efferent lymph(top profilein each paneo andafferent
lymph(bottomprofilein eachpanel) stained with mAbs. Macrophages andmonocytes were excluded
from analysis by gating on 0° and 90° light scatter. Fluorescence intensity is log scale.
Sheep
leukocyte
molecule
mAb clone
number Isotype Distribution Reference
CD5 25-91 IgGl Present on all T lymphocytes; 11
absent from B lymphocytes
CD4 44-38 IgG2a Present on subset of T lymphocytes 13
44-97 IgG1 that are CD8- , SBU-T19- ; 14
absent from B lymphocytes
CD8 38-65 IgG2a Present on subset of T lymphocytes 13,14
that are CD4- , SBU-T19- ;
absent from B lymphocytes
SBU-T19 19-19 IgGi Present on subset of T lymphocytes 14
that are CD4- , CD8- ; absent
from B lymphocytes
MHC class 1 41-19 IgGI Most somatic cells 15
MHC class II 28-1 IgGl Present on B lymphocytes and 16
activated T lymphocytes
CDI 20-27 IgG1 Present on cortical thymocytes, 11
dendritic cells and macrophages,
and B cells in peripheral blood1758 LYMPHOCYTE SUBPOPULATIONS IN LYMPH AND BLOOD
TABLE II
Distribution of Lymphocyte Subpopulations between Popliteal Lymph Node, Blood, and the
Afferent and Efferent Lymph of a Popliteal Lymph Node
* Arithmetic means offour sheep. Comparisons of the percentages ofeach subpopulation between the com-
partments were made using the Mann-Whitney U test . Unless specified, there were no significant differ-
ences between compartments as P 4 0.05.
Significantly different at P 4 0.05 from other values in the same column.
4 Significantly different at P 4 0.05 from the other values in the column with the same footnote.
II Significantly different at P 4 0.05 from the other values in the column with the same footnote.
dividual sheep, andthe cells were reacted withthe panel ofmAbs (Table I)and were
analyzed using flow cytometry.
The distribution oflymphocyte subsets analyzed using flow cytometry is shown
in Fig. 1 and Table II. CD5' lymphocytes were the major lymphocyte subpopula-
tion in all compartments examined. The higher percentage of CD5' lymphocytes
in afferent lymph was statistically different from the percentage of CD5' lympho-
cytes in blood, efferent lymph, orin thelymphnode, and wasassociated with a much
lower percentage of sIg' lymphocytes. Another difference in the distribution of
CD5' lymphocytes was that nearly 25% of T cells in afferent lymph were SBU-
T19' . This was in marked contrast to the much lower percentage of SBUT19' cells
in the lymph node, the efferent lymph draining the node, or the blood supplying
the node.
The SBUT19' lymphocyte subset in sheep is unique in that these cells are CD5' ,
but CD4- , CD8- , and sIg- . The cellular lineage ofthese cells was uncertain, a]-
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FIGURE 2.
￿
MHC antigen expression and cell size ofafferent andefferent lymphocytes. Top profiles
show efferent lymphocytes, and bottom profiles show afferent lymphocytes.
Cell Mean percentage cells stained (SE)*
source CD5 CD4 CD8 SBU-T19 MHC II s1g MHC I
Efferent
lymph 60.3 (6.5) 38.8 (7.7) 14.0 (1 .8)5 10.0 (3.1) 39.5 (7.4) 32.0 (7 .0) 100.00
Afferent
lymph 89.8 (1 .3)1 38.5 (3.7) 12.8 (1 .1)11 27.8 (2.2)1 35.3 (3.8) 7.3 (0 .3)1 100 .00
Peripheral
blood 57 .5 (5 .6) 14.3 (2.7)1 8.5 (0.5)411 11 .8 (2.1) 29.8 (3.8)§ 17.5 (5.3)g 100.00
Lymph
node 55 .5 (6.2) 33 .8 (3 .9) 13.3 (3.1) 6.5 (1 .9) 45.3 (4.9)4 32.3 (3.1)4 100.00MACKAY ET AL.
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TABLE III
Hourly Output of Lymphocyte Subpopulations from Afferent and
Efferent Popliteal Lymph from an Individual Sheep
Percentage staining was assessed by indirect immunofluorescence and flow cytom-
etry. Cell outputs and fluorescent staining were determined from an 8-h collec-
tion oflymph collected at least 3 d after surgery, at a time when the lymph output
was regarded as physiologically normal and free from RBC and granulocyte con-
tamination .
though they were originally described as T cells (14) based on the fact they are
CD5+ and appear in the thymus during early ontogeny (17). Recently, however,
using a rabbit anti-human CD3 antisera, immunoprecipitation ofCD3 molecules
prepared from a lysate made from purified SBUT19' cells showed the presence of
three CD3 bands migrating at 19 kD, 20 kD, and 24 kD. CD4or CD8 antigens could
not be precipated from the lysate. (Hein, W., M.-F. Beya, R. Kudo, C. Mackay,
and S. McClure, manuscript in preparation).
The percentage ofCD4' lymphocytes was much higher in the lymph node and
in afferent and efferent lymph compared withblood although there wasnosignificant
difference in the distribution ofCD4+ cells between the two lymph compartments
and the lymph node. The percentage ofCD8+ lymphocytes was higher in afferent
and efferent lymph than in peripheral bloodbuttherewere no significant differences
between the lymph node and the two lymph compartments.
A further lymphocyte subset that was CD5+ but negative for all other markers
was present in peripheral blood (22%) and afferent lymph (11%) but could not be
demonstrated inthe lymph node orefferent lymph. The percentage ofnull cells (cells
that didnot expresseither CD5 ofsIg) also varied between the compartments exam-
ined. For example, the percentage of null cells in afferent and efferent lymph was
<8% compared with up to 25% null cells in blood.
Expression ofMHCAntigenson Cellsin Different Lymphoid Compartments.
￿
Lymphocytes
from afferent lymph, efferent lymph, the lymph node and blood were analyzed for
expression ofMHC classI and classII antigens by immunofluorescent staining and
flow cytometry. mAbs used for analysis were reacted with cells under saturating
antibody-binding conditions. The percentage of MHC class II' lymphocytes was
the same in allcompartments except thelymph node where thepercentage ofMHC
class II' lymphocytes was significantly higher than blood. A striking difference in
the distribution of MHC class II' lymphocytes was found in afferent lymph com-
pared with other compartments where nearly 30% ofT cells were MHC class W.
Alllymphocytesin blood, efferent andafferent lymph, andlymph nodes were MHC
Small lymphocyte
population
Output of cells/hour
Afferent lymph Efferent lymph
x10 -1 % x10
Total 0.96 54.01
CD5 0.85 87 27 .70 54
CD4 0.24 32 15 .92 31
CD8 0.07 9 5 .64 11
MHC class II 0.24 25 18.55 36
sIg 0.06 8 17 .42 34
SBU-T19 0.24 25 3 .60 71760
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FIGURE 3 .
￿
Immunoperoxidase staining ofafferent lymphatic cells by mAbs. CDl (20-27), showing
reactivity with large macrophage/dendritic cells, but not with lymphocytes (top ; x 160) . MHC
class II (28-1), showing intense staining of macrophages and dendritic cells and staining ofsome
lymphocytes (bottom ; x 160) .
class I+ . However, Fig . 2 demonstrates that there was a much higher density of
MHC class I antigens expressed on lymphocytes in afferent lymph than on lympho-
cytes in blood or efferent lymph . Forward angle light scatter (cell size) analysis re-
vealed that afferent lymph lymphocytes were only slightly larger than lymphocytes
from efferent lymph (Fig . 2) .
Output ofLymphocyte Subpopulationsfrom Afferent and Efferent PoplitealLymph.
￿
Table
III shows the hourly output oflymphocytes from popliteal efferent and afferentlymph
of an individual sheep . The hourly output of small lymphocytes from efferent lymph
was 50 times greater than from afferent lymph . Only one afferent lymphatic was
cannulated, however, the total input of small lymphocytes from afferent lymph does
not exceed 5-10% of the output from efferent lymph (5) .
Clearly, the output oflymphocyte subpopulations from afferent lymph, no matter
how enriched for a givenlymphocyte subpopulation, cannot account for differences
in the outputs of lymphocyte subsets observed in efferent lymph . This is apparent
even for subpopulations in efferent lymph such as SBUT19+ cells where the hourly
output was only -3-6 x 106 yet the total afferent hourly output was an estimated
106 . This was despite the fact that SBUT19+ cells were present in four times the
concentration in afferent lymph than efferent lymph .MACKAY ET AL .
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FIGURE 4 .
￿
Section ofsheep popliteal lymph node showing the distribution ofSBUT19' (x 100) .
Stained cells were localized to the subcapsular sinus, trabeculae, and to the medulla, butwere
largely absent from B cell follicles andT cell domains .
Immunoperoxidase Staining of CytocentrifugedAfferent Lymphatic Cells.
￿
The phenotype
ofmacrophages in afferent lymph was examined usingimmunoperoxidase staining
on cytospots . All macrophages showed strong expression ofMHC class II antigens
(Fig . 3) . CDl was expressed on virtually all macrophages, but not by lymphocytes
(Fig . 3) . Many of the macrophagespossessed long intensely stained "veils" and were
taken to represent dendritic cells . CD4 was also expressedon -50% ofmacrophages.
Distribution ofSBUT19' Cells in Lymph Nodes ofSheep.
￿
Fig . 4 shows a peripheral
lymph node stained for SBUT19 . SBUT19+ cells were prominent in the outer
cortex close to the subcapsular sinus and were also associated with trabeculae and
medullary sinuses . SBUT19' cells were usually scattered sparsely throughout the
deep cortex and medulla and were absent from B cells follicles.
Discussion
The experiments described in this report are the first to examine simultaneously
the distribution of lymphocyte subsets circulating in blood and in the afferent lymph
and efferent lymph of a peripheral lymph node . Within these compartments, marked
differences in the percentages of certain lymphocyte subsets were apparent, which
suggests that certain lymphocyte subsets may leave the blood with differing efficien-
cies . Lymphocyte subpopulations also appear to be extractedfrom theblood at different
rates by the lymph node as opposed to subcutaneous vascular endothelium .
The distribution of lymphocytes within different anatomical sites throughout the
body depends upon both the delivery of cells to a tissue by the blood and the ca-
pacity of lymphocytes to cross specialized endothelium at those sites . Analysis of
lymphocyte recirculation in sheep hasdemonstrated that there are at leastthree sub-
populationsof lymphocytes that recirculateby different pathways . Lymphocytes from1762
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intestinal lymph recirculate preferentially back into intestinal lymph, whereas lym-
phocytes from peripheral lymph nodes recirculate preferentially back into periph-
eral lymph node efferent lymph (6, 18, 19) . A third population of lymphocytes has
been shown to recirculate preferentially to lymph draining sites of chronic inflam-
mation (20). The exit of circulating lymphocytes from blood may be controlled by
specific molecular interactions between lymphocytes and endothelial cells(21). Thus
different lymphocyte-endothelial cell interactions may occur in various tissues ena-
bling lymphocytes to migrate preferentially to peripheral lymph nodes, to gut, or
to sites of inflammation (3, 21, 22).
The differences in the distribution oflymphocyte subpopulations between the various
lymphoid compartments reported in this paper may result from lymphocyte subsets
bearing different migration-related cell surface molecules. Accordingly, endothelial
cells would express complementary cell surface molecules that would differ from vas-
cular bed to vascular bed either in the nature of the molecules expressed or in their
number.
In this study, CD5+ lymphocytes were present in a much higher concentration
in afferent lymph than in blood or efferent lymph. However, traffic endothelium in
lymph nodes transmitted many more CD5 + cells than in subcutaneous vascular
beds (see Table III) although the delivery of lymphocytes to both vascular beds was
estimated to be similar. It follows that the lymph node vascular bed as a whole is
far more efficient at transmitting CD5' lymphocytes into efferent lymph than the
subcutaneous vascular bed as a whole is in transmitting CD5+ lymphocytes into
afferent lymph. The enrichment of CD5+ cells compared with B cells in afferent
lymph as opposed to efferent lymph could be explained if subcutaneous vascular
endothelium transmits CD5+ lymphocytes in preference to B lymphocytes, either
by positively selecting for the former or negatively selecting for the latter. Differ-
ences in the migration of T lymphocyte subsets at lymph nodes and the skin and
subcutaneous tissues could be explained by the expression ofdifferent cell migration-
related cell surface molecules on each lymphocyte subset associated with quantita-
tive differences in the expression ofcomplementary molecules on traffic endothelium.
For example, if the complementary molecule to a migration-related cell surface mol-
ecule specific for SBUT19' lymphocytes was expressed in greater numbers on sub-
cutaneous vascular endothelium than on endothelium in lymph nodes, SBUT19+
lymphocytes may bind to endothelium more efficiently in the subcutaneous tissues
resulting in a higher extraction rate for SBUT19' cells from blood into afferent
lymph than for blood into efferent lymph. If this notion is correct, the endothelium,
not the lymphocyte, is the key factor in regulating the nonrandom exit of lympho-
cyte subsets from different vascular beds.
The higher concentration of T lymphocytes and their subpopulations in afferent
lymph compared with blood could also be explained if T lymphocytes were dividing
in the tissue spaces after they left the blood and before they appeared in afferent
lymph. The modal transit time of T lymphocytes from blood to afferent lymph is
ti 18-20 h and is the same as the transit time of T lymphocytes from blood through
the lymph node into efferent lymph (23). Such an explanation would require a high
turnover of T lymphocytes in the tissue spaces for which there is no evidence. How-
ever, there is evidence that in a nonstimulated lymph node such as those examined
in our study, < 2-3 of lymphocytes in efferent lymph are newly formed (4), so theMACKAY ET AL.
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higher concentration ofCD4+ lymphocytes in efferent lymph compared with blood
could not be due to the proliferation of CD4` lymphocytes in the lymph node.
The percentages of CD4' and CD8` lymphocytes in sheep blood were much
lower than those reported for human blood. Typically, the CD4+ and CD8+ subsets
represent 20-25% and 10-12% ofsheep PBL, respectively(13), although in this study
thevalues for these subsetswere even lower. Sheepblood alsohas a higher percentage
ofB cells than human blood, as well as 10-15% SBUT19' cells. An analogous popu-
lation in human blood to SBUT19 could be represented by the CD3+, CD5+,
CD4- , and CD8- subset that expresses the y chain of the T cell receptor (24).
Human andmouselymphokine-activated killer effector cells, but not precursorcells,
can show a similar phenotype to SBUT19 cells, although CD3 `, CD4- , and CD8-
T cells in human peripheral blood constitute only 3% of lymphocytes (25).
The SBUT19 subset exhibited an interesting distribution in lymph nodes where
they were located mainly in the subcapsularcortex and adjacent to trabeculae. Few
SBUT19' cells were observed within conventional T cell or B cell domains. The
high concentration of SBUT19+ lymphocytes in afferent lymph could partly account
for their unusual distribution in the lymph node although it must be conceded that
the majority of SBUT19` lymphocytes in lymph nodes at any one time will have
entered the lymph node via lymph node vascular endothelium. Any consideration
of the contribution to the output of SBUT19+ lymphocytes in efferent lymph by
cellsfrom afferent lymph should take into accountthat, as far aswe are aware, afferent
lymph lymphocytes have never actually been shown to migrate into efferent lymph.
The majority oflymphcytes in afferent lymph express greater amounts ofMHC
class I antigen than lymphocytes in efferent lymph or blood. We have no explana-
tionfor how this occurs. We alsohave noexplanation for thelarge numbersofMHC
class II+ T lymphocytes in afferent lymph although in both cases it seems likely that
altered expression of MHC antigens occurs after lymphocytes have left the blood
and before they haveentered afferent lymph. There is no direct evidenceto support
this proposition nor is there any evidence to support the notion that such lympho-
cyteshave migrated preferentially into afferent lymph because theybear MHC class
II antigens. The observed expression ofMHC antigens on lymphocytes in afferent
lymph is all the more confusing in view of their anergy in graft-vs.-host reactions
as reported by Scollay & Lafferty (7). Studies on human afferent lymph have also
shown a high percentage ofT cells that express MHC class 11 antigens (26). Other
studies on afferent lymph cells in sheep have not demonstrated large numbers of
MHC class IV cells, although increased levels of MHC class II expression were
observed afterantigenic stimulation. The same study reported complete de novo syn-
thesis by efferent T cells from undetectable levels to nearly double the number of
class II molecules found on B cells after immunological stimulation (27).
10-20% ofcells in afferent lymphare large macrophage-like cells. Their presence
in afferent lymph raises the question of their origin and subsequent fate after en-
tering the node since they are not seen in efferent lymph. The phenotypic analysis
ofafferent lymph macrophages reported here supports the ideathat at leastapropor-
tionofthesecells are Langerhans'cells thathave migrated fromthe skin. All afferent
lymph dendritic cells were intensely MHC class II' and CDl+ while -50% were
CD4', similarto the phenotype of Langerhans' cells in human epidermis (28). The
CDl' veiled dendritic cells in afferent lymph may be Langerhans' cells that have1764
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left the epidermis, but the relationship of these cells to Langerhans' cells is difficult
to define in sheep because they do not contain Birbeck granules although they do
phagocytose immune complexes in vivo (29).
Summary
The surface phenotypes (CD1, CD4, CD5, CD8, SBUT19, MHC class I, MHC
class II, and sIg) of cells in blood, lymph nodes, and lymph were determined to
examine simultaneously the distribution oflymphocyte subsets circulating in blood,
afferent lymph, and efferent lymph ofa peripheral lymph node. Marked differences
in the percentage of certain lymphocyte subsets were apparent within the compart-
ments examined, suggesting that lymphocyte subsets leave the blood with differing
efficiencies. Lymphocyte subsets also appeared to be extracted from the blood at
different rates by lymph node as opposed to subcutaneous vascular endothelium.
Endothelial cells in different vascular beds may express different numbers ofmolecules
complementary to a set of migration-related cell surface molecules specific for each
lymphocyte subset. Accordingly, the vascular endothelium would be the key factor
in regulating nonrandom cell migration.
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